EVH — Evolent Health, Inc.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1628908 ·
Last close
$4.72
Market Cap
$533.64M
52W High
$6.26
52W Low
$2.95
ADV30
3,793,547
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 652,520,000 | 80,836,000 | -9,561,000 | -28,364,000 | 1,971,894,000 | 115,703,000 | 1,588,671,000 |
| Mar 2026 | 496,246,000 | 83,774,000 | -10,599,000 | -26,632,000 | 1,878,847,000 | 142,028,000 | 1,482,454,000 |
| Dec 2025 | 468,719,000 | 97,253,000 | -20,440,000 | -429,131,000 | 1,899,236,000 | 151,856,000 | 1,484,042,000 |
| Sep 2025 | 479,533,000 | 99,774,000 | -1,433,000 | -20,864,000 | 2,453,459,000 | 116,650,000 | 1,611,226,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$54,316,000
Investing CF
$-31,026,000
Financing CF
$-149,817,000
CapEx
$-29,978,000
Dividends Paid
$-1,929,000
Buybacks
$0
EPS Diluted TTM
$-4.57
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,370,323,000
Inventory
—
Receivables
$449,118,000
ST Investments
—
EBIT TTM
$-433,503,000
Pretax Income TTM
$-502,137,000
Interest Exp TTM
$68,634,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,097,017,984
EBITDA
$61,037,000
Free Cash Flow
$184,295,008
Enterprise Value
$1,388,371,072
Total Cash
$115,703,000
Total Debt
$970,433,984
Shares Out
113,059,335
Trailing EPS
$-4.49
Book Value
$3.40
ROE
-67.0%
ROA
-0.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,876,229,000 | -19,834,000 | -534,510,000 | 1,899,236,000 | 1,484,042,000 | — | 38,843,000 |
| Dec 2024 | 2,554,741,000 | -14,067,000 | -61,623,000 | 2,544,411,000 | 1,543,152,000 | — | 18,765,000 |
| Dec 2023 | 1,963,896,000 | -21,055,000 | -113,040,000 | 2,680,308,000 | 1,612,607,000 | — | 142,582,000 |
| Dec 2022 | 1,352,013,000 | -19,880,000 | -19,164,000 | 1,817,293,000 | 957,876,000 | — | -11,553,000 |
TTM Snapshot
Revenues TTM
$1,707,472,000
NetIncome TTM
$-59,378,000
OpCashFlow TTM
$0
Assets (Latest)
$2,544,411,000
Forward EPS
$0.39
Max Pain — expiry 2027-01-15
max pain strike: $5.00 · spot: $4.64 · call oi: 3,763 · put oi: 1,378
Expected Move to 2027-01-15:
±$2.17
(46.93%) —
implied range
$2.46 –
$6.81
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VKQ | Invesco Municipal Trust | $536.75M | $9.70 | — |
| BGY | BlackRock Enhanced International Dividend Trust | $530.09M | $5.85 | — |
| ONT | Onterris, Inc. | $538.35M | $15.33 | — |
| IQI | Invesco Quality Municipal Income Trust | $527.25M | $9.97 | — |
| SLDP | Solid Power, Inc. | $524.82M | $2.30 | — |
News headlines (Yahoo Finance, 1h cache)
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call
2026-08-15 03:09 · Yahoo
Evolent Health (EVH) Q2 2026 Earnings Call Transcript
2026-08-13 17:45 · Yahoo
Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Revenue Surges 31% and Guidance ...
2026-08-06 19:03 · Yahoo
Compared to Estimates, Evolent Health (EVH) Q2 Earnings: A Look at Key Metrics
2026-08-06 13:30 · Yahoo
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
2026-07-31 19:55 · Yahoo
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
2026-08-16 04:45 · Yahoo
3 Stocks Under $10 with Questionable Fundamentals
2026-08-12 07:09 · Yahoo
EVH Q2 2026 Deep Dive: Oncology Suite and AI Automation Drive Growth Amid Membership Headwinds
2026-08-10 04:29 · Yahoo
Evolent Health Q2 Earnings Call Highlights
2026-08-08 07:04 · Yahoo
Evolent Health, Inc. Q2 2026 Earnings Call Summary
2026-08-06 22:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.